BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18212552)

  • 1. Hepatocellular carcinoma presenting as a precocious cutaneous metastasis.
    Royer MC; Rush WL; Lupton GP
    Am J Dermatopathol; 2008 Feb; 30(1):77-80. PubMed ID: 18212552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings.
    Terada T; Sugiura M
    Int J Surg Pathol; 2010 Oct; 18(5):433-6. PubMed ID: 18499685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma with cutaneous metastasis.
    Al-Mashat FM
    Saudi Med J; 2004 Mar; 25(3):370-2. PubMed ID: 15048180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
    Karabork A; Kaygusuz G; Ekinci C
    Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of metastatic cutaneous nodules of recurrent hepatocellular carcinoma].
    Cho M; Choi CS; Seo GS; Kim TH; Choi SC; Yun KJ; Kim HC
    Korean J Hepatol; 2007 Jun; 13(2):234-8. PubMed ID: 17585197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR; Susani M; Wrba F; Haitel A
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
    Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous metastasis of hepatocellular carcinoma diagnosed by fine needle aspiration cytology and Hep Par 1 immunopositivity.
    Isa NM; Bong JJ; Ghani FA; Rose IM; Husain S; Azrif M
    Diagn Cytopathol; 2012 Nov; 40(11):1010-4. PubMed ID: 21563319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical presentation of hepatocellular carcinoma.
    UyBarreta V; Mikesh C; Simmons B; Beech DJ
    South Med J; 2000 May; 93(5):516-9. PubMed ID: 10832956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous metastases of hepatocellular carcinoma.
    Lazaro M; Allende I; Ratón JA; Acebo E; Diaz-Perez JL
    Clin Exp Dermatol; 2009 Dec; 34(8):e567-9. PubMed ID: 19489869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous metastasis of hepatocellular carcinoma following liver transplantation.
    Queen D; Fisher J; Husain S; Linos K; Niedt GW; Samie FH
    J Cutan Pathol; 2020 Jan; 47(1):47-51. PubMed ID: 31381162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
    Kanitakis J; Chouvet B; Claudy A; Scoazec JY
    Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.